Role(s) in Healthcare Innovation:
Patient Activist / AdvocateMy Community
Global Healthcare Innovation
About Me
In 2016, I received a phlebotomy workshop certificate at Mount Sinai Hospital as part of my training for collecting blood for MS patients enrolling in clinical trials. I grew tired of asking patients to wait 43 minutes to 61 minutes to receive their blood draw for diagnostic treatment and/or testing. COVID-19 testing has amplified the need for more blood collection at home to avoid having patient crowds at the hospital/clinic. I have received phone calls about supply shortages for blood collection or mobile phlebotomists who were not available in the NYC area. Purple Inc, is a COVID-19 start-up building a mobile phlebotomy database so all resources for blood collection are on the website to provide faster care, and good mobile healthcare guidelines and practices.
Interested in solutions for:
For my patients I am working on a great new idea for healthcareI am looking for healthcare innovations:
COVID-19 Home-Based Care Hospital Solutions Medical Device
You have not backed any projects.
Lets change that!
Discover Projects
No comments on any project yet.
Lets change that!
Discover Projects
No data found.
Lets change that!
Discover Projects
No data found.
Lets change that!
Discover Projects
No data found.
Lets change that!
Discover Projects
No data found.
Lets change that!
Discover Projects
No data found.
Lets change that!
Discover Projects
No data found.
Lets change that!
Discover Projects
No data found.
Lets change that!
Discover Projects
No project reviewed yet.
Lets change that!
Discover Projects
Important Disclosure: MedStartr.com is a website owned and operated by MedStartr, Inc., which is not a broker-dealer, funding portal or investment advisor; and neither the website nor MedStartr, Inc. participate in the offer or sale of securities. All securities related activity is conducted through Young America Capital, LLC, a registered broker-dealer and member of FINRA/SIPC. No communication, through this website, email or in any other medium, should be construed as a recommendation for any securities offering.